3 studies found for:    20472939 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS
Conditions: Respiratory Distress Syndrome;   Hyaline Membrane Disease
Interventions: Drug: Poractant alfa, 200 mg/kg;   Device: Ventilator for High-frequency Oscillatory Ventilation (HFOV);   Device: Nasal Continuous Positive Airway Pressure (nCPAP)
2 Completed Assessment of Lung Aeration at Birth
Condition: Bronchopulmonary Dysplasia
Interventions: Procedure: "IPPV group";   Procedure: SI group
3 Active, not recruiting
Has Results
Surfactant Positive Airway Pressure and Pulse Oximetry Trial
Conditions: Infant, Newborn, Diseases;   Other Preterm Infants;   Infant, Small for Gestational Age;   Premature Birth;   Bronchopulmonary Dysplasia;   Retinopathy of Prematurity
Interventions: Drug: Surfactant;   Device: Continuous Positive Airway Pressure (CPAP);   Drug: Supplemental oxygen with target saturation of 85 to 89%;   Drug: Supplemental oxygen with target saturation of 91 to 95%

Indicates status has not been verified in more than two years